http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2192815-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b43d7dba0f5b5ac7f9c26d9e4dd3605 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate | 1972-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1974-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | FR-2192815-A2 |
| titleOfInvention | Ulcerogenic drug contg transition alumina compsns - for reduced acid-erosion of gastric mucosa, by reserpine, phenylbutazone,aspirin |
| abstract | In therapeutic compsns. contg. as active components (a) alumina of formula 2Al2O3.3H2O prepd. by hydrolysis of Al isopropoxide and (b) a cpd. provoking acid erosion of the gastric mucosa, the highly active 'transition' alumina reduces the ulcerogenic potential. Compsns. contain =50% alumina which may also replace some of the tablet additives esp. microcrystalline cellulose, Ca phosphate or talc. |
| priorityDate | 1972-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.